Cochrane Abstracts
Topotecan for ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topotecan for Ovarian Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434279/all/Topotecan_for_ovarian_cancer.
Topotecan for ovarian cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434279/all/Topotecan_for_ovarian_cancer. Accessed November 23, 2024.
Topotecan for ovarian cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434279/all/Topotecan_for_ovarian_cancer
Topotecan for Ovarian Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434279/all/Topotecan_for_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topotecan for ovarian cancer
ID - 434279
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434279/all/Topotecan_for_ovarian_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
